David Lockhart, ReCode Therapeutics CEO

Pfiz­er throws its weight be­hind LNP play­er eye­ing mR­NA treat­ments for CF, PCD

David Lock­hart did not see the me­te­oric rise of mes­sen­ger RNA and lipid nanopar­ti­cles com­ing.

Thanks to the world­wide fight against Covid-19, mR­NA — the ge­net­ic …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.